Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Clinical Hematology International|October 1, 2021
Robust Selections of Various Hematopoietic Cell Fractions on the CliniMACS Plus InstrumentSandhya R Panch, Opal L Reddy, Katherine Li, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 16, 2010
NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the scienceMitchell S Cairo, Craig T Jordan, Carlo C Maley, et al.Journal of Cell Science|August 2, 2003
Drosophila Rheb GTPase is required for cell cycle progression and cell growthParthive H Patel, Nitika Thapar, Lea Guo, et al.Pediatric Blood & Cancer|January 31, 2024
Percutaneous biopsy for the diagnosis, risk stratification, and molecular profiling of neuroblastoma: A single-center retrospective studySean Schoeman, Rochelle Bagatell, Anne Marie Cahill, et al.Pediatric Blood & Cancer|April 28, 2006
Treatment late effects in long-term survivors of pediatric sarcomaPatrick Mansky, Andrew Arai, Pamela Stratton, et al.Pediatric Blood & Cancer|June 6, 2013
Proton versus photon radiation therapy for patients with high-risk neuroblastoma: the need for a customized approachChristine Hill-Kayser, Zelig Tochner, Stefan Both, et al.Cancer Cell International|April 16, 2011
A 6-gene signature identifies four molecular subgroups of neuroblastomaFrida Abel, Daniel Dalevi, Maria Nethander, et al.Cancer Research|November 4, 2005
Proliferation of human neuroblastomas mediated by the epidermal growth factor receptorRuth Ho, Jane E Minturn, Tomoro Hishiki, et al.Blood Advances|September 14, 2021
Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapyAndrew Johnsrud, Juliana Craig, John Baird, et al.Journal for Immunotherapy of Cancer|May 9, 2022
Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulationElizabeth M Holland, John C Molina, Kniya Dede, et al.Pageof 6